Search Results - L. Leyre
- Showing 1 - 4 results of 4
-
1
OP 2.3 - 00117 The EZH2 inhibitor Tazemetostat increases MHC I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs by A. Gramatica, A. Danesh, I. Miller, J. Weiler, F. Khan, D. Copertino, U. Chukwukere, L. Leyre, B. Jones
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
PP 4.16 - 00188 Investigating the Role of Naïve CD4+ T-cells as a CTL Resistant Sanctuary for Intact HIV Proviruses by J. Weiler, W.D. Conce Alberto, Y. Ren, S. Han Huang, L. Leyre, A. Gramatica, S. Terry, R. Brad Jones
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
HIV persistence in lymph nodes from virally suppressed individuals: residual production VS latency by M. Pardons, R. Fromentin, L. Leyre, A. Pagliuzza, P. Vohra, D. Ng, R. Hoh, M. Kerbleski, V. Tai, J. Milush, F. Hecht, S. Deeks, N. Chomont
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
PP 4.15 - 00181 Distinctive cytoskeletal properties are implicated in the resistance of a fraction of productively HIV-infected CD4+ T-cells to killing by cytotoxic T lymphocytes (... by L. Leyre, A. Herrera, P. Zumbo, J. Weiler, Y. Zhang, E. McNeil, N. Linden, D. Betel, S.R. Manalis, R.B. Jones, D.C. Copertino, S. Terry
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book